COPD Re-Exacerbation No Greater on
Short-Course Steroids
Despite guidelines calling for longer treatment periods, a new study has found that a 5-day course of glucocorticoids is noninferior to the conventional 14-day course in avoiding COPD re-exacerbation in hospitalized patients.
How did the 6-month outcomes compare between the two groups of study subjects?